ABM-125

N/A

Report date: 2025/05/20 15:34:37

Base Information

Drug NameABM-125
Drug Alias NameABM-125LNR 125.38LNR-125
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInterleukin-25 inhibitors
TargetsInterleukin-25
Therapy Area/IndicationsDermatitis, AtopicIdiopathic Pulmonary FibrosisAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbeome Corp
China Registration ClassN/A

Develop Information

Active CompaniesAbeome Corp
Inactive CompaniesN/A
Active IndicationsDermatitis, AtopicIdiopathic Pulmonary FibrosisAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A